Recurrent Epithelial Ovarian Cancer
Oncology·MeSH: Carcinoma, Ovarian Epithelial
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 1(1)
| Drug | Company |
|---|---|
| lira-cel | Anixa Biosciences Inc (ANIX) |
Frequently asked questions
How many drugs are in development for Recurrent Epithelial Ovarian Cancer?
BioSniper tracks 1 drug in development for Recurrent Epithelial Ovarian Cancer across 1 company.
How many clinical trials target Recurrent Epithelial Ovarian Cancer?
There are 1 clinical trial targeting Recurrent Epithelial Ovarian Cancer tracked by BioSniper.
Deep-dive into Recurrent Epithelial Ovarian Cancer
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis